New knee shot for arthritis passes first safety check
NCT ID NCT06704932
First seen Jan 12, 2026 · Last updated May 09, 2026 · Updated 13 times
Summary
This study tested a single injection of a new drug (SAR446959) in the knees of 32 adults aged 45-65 with osteoarthritis. The main goal was to check safety and side effects, not to prove it works. Participants were followed for about 28 weeks to monitor any reactions and how the drug moved through the body.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OSTEOARTHRITIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Investigational Site Number : 2760001
Berlin, 14050, Germany
Conditions
Explore the condition pages connected to this study.